These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6632176)

  • 41. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
    Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertension secondary to early-stage kidney disease: the pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells.
    Schiffl H; Fricke H; Sitter T
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):51-7. PubMed ID: 8494019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.
    Beretta-Piccoli C; Weidmann P; Schiffl H; Cottier C; Reubi FC
    Kidney Int; 1982 Sep; 22(3):297-303. PubMed ID: 7176332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of sodium-restricted diet and posture on norepinephrine kinetics in humans.
    Linares OA; Zech LA; Jacquez JA; Rosen SG; Sanfield JA; Morrow LA; Supiano MA; Halter JB
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E222-30. PubMed ID: 3348372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age differences in plasma norepinephrine kinetics in humans.
    Veith RC; Featherstone JA; Linares OA; Halter JB
    J Gerontol; 1986 May; 41(3):319-24. PubMed ID: 3700981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Norepinephrine clearance is increased during acute hypoxemia in humans.
    Leuenberger U; Gleeson K; Wroblewski K; Prophet S; Zelis R; Zwillich C; Sinoway L
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1659-64. PubMed ID: 1951753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertensives' pressor response to norepinephrine. Analysis by infusion rate and plasma levels.
    Ziegler MG; Mills P; Dimsdale JE
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):586-91. PubMed ID: 1873013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Norepinephrine release in the human forearm: effects of epinephrine.
    Stein CM; Nelson R; He HB; Wood M; Wood AJ
    Hypertension; 1997 Nov; 30(5):1078-84. PubMed ID: 9369259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norepinephrine and forearm vascular resistance responses to tilt and cold pressor test in essential hypertension: effects of aging.
    Sowers JR; Mohanty PK
    Angiology; 1989 Oct; 40(10):872-9. PubMed ID: 2802257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sympathetic nervous system in essential hypertension.
    Tuck ML
    Am Heart J; 1986 Oct; 112(4):877-86. PubMed ID: 3532745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.
    Esler M; Jackman G; Leonard P; Bobik A; Skews H; Jennings G; Kelleher D; Korner P
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():311s-313s. PubMed ID: 7449275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-related differences in norepinephrine kinetics: effect of posture and sodium-restricted diet.
    Supiano MA; Linares OA; Smith MJ; Halter JB
    Am J Physiol; 1990 Sep; 259(3 Pt 1):E422-31. PubMed ID: 2205110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
    J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension.
    Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
    Hypertension; 1983; 5(5):767-71. PubMed ID: 6618639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response.
    Wirtz PH; Ehlert U; Bärtschi C; Redwine LS; von Känel R
    Metabolism; 2009 Jan; 58(1):30-7. PubMed ID: 19059528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs.
    Cowley AW; Lohmeier TE
    Hypertension; 1979; 1(6):549-58. PubMed ID: 396248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sympathetic reactivity during a yohimbine challenge test in essential hypertension.
    Goldstein DS; Grossman E; Listwak S; Folio CJ
    Hypertension; 1991 Nov; 18(5 Suppl):III40-8. PubMed ID: 1657775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertension.
    Campese VM; Romoff M; Telfer N; Weidmann P; Massry SG
    Kidney Int; 1980 Sep; 18(3):351-7. PubMed ID: 7007709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.